Kane Biotech Engages Independent Trading Group to Improve Share Liquidity

• Kane Biotech engaged Independent Trading Group for market-making services, subject to TSX Venture Exchange approval.
• ITG will trade common shares on the TSXV and other venues to maintain a reasonable market and improve liquidity.
• The monthly fee is $5,000, excluding applicable taxes, with no performance-based compensation, shares or options.
• The initial one-month agreement renews automatically for successive one-month terms; either party can terminate with at least 30 days’ written notice.
• The firms are unaffiliated; neither ITG nor its principals held direct or indirect interests in the company’s securities when the agreement began.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kane Biotech Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610211705PRIMZONEFULLFEED9849975) on October 21, 2026, and is solely responsible for the information contained therein.